Table 1.
Characteristics of patients with and without AEs
| Variables | Patients with AEs (n = 46) |
Patients without AEs (n = 7) |
p value |
|---|---|---|---|
| Age (years) | 7.00 (4.44) | 6.00 (2.64) | 0.802a |
| Weight (kg) | 27.04 (18.17) | 22.40 (11.46) | 0.813a |
| Height (cm) | 115.66 (26.68) | 111.00 (16.27) | 0.727a |
| Female, n (%) | 25 (54.35) | 3 (42.86) | 0.694a |
| High risk ALL, n (%) | 27 (58.70) | 3 (42.86) | 0.451a |
| Standard risk ALL, n (%) | 19 (41.30) | 4 (57.14) | 0.451a |
| Completed RICP, n (%) | 43 (93.48) | 7 (100) | 0.487a |
| ALL remission, n (%) | 45 (97.83) | 7 (100) | 0.694a |
| Deaths, n (%) | 4 (8.70) | 0 (0) | 0.417a |
| Time to get ALL remission (days) | 15.55 (5.97) | 15.28 (3.35) | 0.747a |
| First hospital length of stay (days) | 9.33 (13.65) | 1.86 (4.91) | 0.006a |
| Second hospital length of stay (days) | 6.62 (9.74) | 0.14 (0.37) | 0.101a |
| Third hospital length of stay (days) | 1.35 (6.25) | 0 (0) | 0.491a |
| Amount of AEs by patient | 6.46 (6.06) | 0 (0) | < (0) 01a |
The values shown are mean and standard deviations except for percentages
AEs Adverse events
aWilcoxon rank sum test